Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangqi Guizhi Wuwu Decoction in Diabetic Nephropathy
NCT05418465Unknown
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Randomised, open-label trial of huang qi gui zhi wu wu tang in diabetic nephropathy (DN) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Rate of change in Estimated Glomerular Filtration Rate (eGFR) compared to baseline at 12 weeks. Status: unknown.
02
Drugs
huang qi gui zhi wu wu tang
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT05418465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05418465.